Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

Etats-Unis|Canada
English|French

Twist Bioscience Corp

(NASDAQ: TWST)
Ajouter à Portefeuille
+1,07 (+2,62%)
en date du mai 31, 2024

Dernière 41,90
Variation +1,07 (+2,62%)
Ouverture 41,24
Clôture précédente 40,83
Écart (actuel)
39,60
42,54
Écart 52 semaines
14,29
50,50
Volume 1 395 400
Volume Moyen 1 244 425
Secteur SIC-2836 Biological Products, (No Disgnostic Substanc

Perfomance Comparison

Nom Aujourd'hui 3-mois 1 an
TWST +2,62% +18,33% +190,77%
DJIA +1,51% -2,09% +16,90%
S&P 500 +0,80% +1,01% +25,49%

Statistiques clef

BPA Annuel -3,36
Rendement dividendes 0,00%
Rapport Prix/Bénéfices N/A
Market Capitalization, $K 2 369 220
Alpha pondéré +74,55
Écart-type +0,38
Marge d'exploitation -69,24%
Beta 1,64

Taux de croissance

Cette année +13,67%
1 An(s) +156,90%
3 An(s) -56,51%
5 An(s) +61,15%

Opinion

Vendre Conserver Acheter

Articles récents

Twist Bioscience to Present at Upcoming Investor

Business Wire - Thu May 23, 07:00AM CDT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will present and participate i(version intégrale)
TWST: 41,90 (+1,07)

Twist Bioscience Launches Multiplexed Gene Fragments

Business Wire - Mon May 13, 07:00AM CDT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Twist Multiplexed Gene Fragments (version intégrale)
TWST: 41,90 (+1,07)

Twist Bioscience Corporation Announces Inducement

Business Wire - Wed May 08, 07:00AM CDT
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers to succeed through its offering of high-quality synt(version intégrale)
TWST: 41,90 (+1,07)

Twist Bioscience: Fiscal Q2 Earnings Snapshot

AP - Thu May 02, 03:33PM CDT
Twist Bioscience: Fiscal Q2 Earnings Snapshot(version intégrale)
TWST: 41,90 (+1,07)

Twist Bioscience Reports Fiscal Second Quarter 2024

Business Wire - Thu May 02, 03:05PM CDT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the (version intégrale)
TWST: 41,90 (+1,07)